1-[4-[7-(cyclopropylmethylamino)-4-oxoquinazolin-3-yl]phenyl]-3-(5-methylthiophen-2-yl)sulfonylurea
C24H23N5O4S2 — CID 71072469
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[7-(cyclopropylmethylamino)-4-oxoquinazolin-3-yl]phenyl]-3-(5-methylthiophen-2-yl)sulfonylurea
1-[4-[7-(cyclopropylmethylamino)-4-oxoquinazolin-3-yl]phenyl]-3-(5-methylthiophen-2-yl)sulfonylurea (PubChem CID 71072469) has the molecular formula C24H23N5O4S2 and a molecular weight of 509.61 g/mol. Its IUPAC name is 1-[4-[7-(cyclopropylmethylamino)-4-oxoquinazolin-3-yl]phenyl]-3-(5-methylthiophen-2-yl)sulfonylurea.
Molecular Properties
| Compound Name | 1-[4-[7-(cyclopropylmethylamino)-4-oxoquinazolin-3-yl]phenyl]-3-(5-methylthiophen-2-yl)sulfonylurea |
|---|---|
| PubChem CID | 71072469 |
| Molecular Formula | C24H23N5O4S2 |
| Molecular Weight | 509.61 g/mol |
| Exact Mass | 509.12 |
| IUPAC Name | 1-[4-[7-(cyclopropylmethylamino)-4-oxoquinazolin-3-yl]phenyl]-3-(5-methylthiophen-2-yl)sulfonylurea |
| SMILES | Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(-n3cnc4cc(NCC5CC5)ccc4c3=O)cc2)s1 |
| InChI | InChI=1S/C24H23N5O4S2/c1-15-2-11-22(34-15)35(32,33)28-24(31)27-17-5-8-19(9-6-17)29-14-26-21-12-18(25-13-16-3-4-16)7-10-20(21)23(29)30/h2,5-12,14,16,25H,3-4,13H2,1H3,(H2,27,28,31) |
| InChIKey | ZUOJVIWEQJJYTP-UHFFFAOYSA-N |
| XLogP | 4.09 |
| TPSA | 122.19 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 509.61 |
| LogP ≤ 5 | 4.09 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71072469 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.